These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33860209)

  • 1. Macrocyclic Gq Protein Inhibitors FR900359 and/or YM-254890-Fit for Translation?
    Schlegel JG; Tahoun M; Seidinger A; Voss JH; Kuschak M; Kehraus S; Schneider M; Matthey M; Fleischmann BK; König GM; Wenzel D; Müller CE
    ACS Pharmacol Transl Sci; 2021 Apr; 4(2):888-897. PubMed ID: 33860209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unraveling binding mechanism and kinetics of macrocyclic Gα
    Voss JH; Nagel J; Rafehi M; Guixà-González R; Malfacini D; Patt J; Kehraus S; Inoue A; König GM; Kostenis E; Deupi X; Namasivayam V; Müller CE
    Pharmacol Res; 2021 Nov; 173():105880. PubMed ID: 34506902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational design of a heterotrimeric G protein α subunit with artificial inhibitor sensitivity.
    Malfacini D; Patt J; Annala S; Harpsøe K; Eryilmaz F; Reher R; Crüsemann M; Hanke W; Zhang H; Tietze D; Gloriam DE; Bräuner-Osborne H; Strømgaard K; König GM; Inoue A; Gomeza J; Kostenis E
    J Biol Chem; 2019 Apr; 294(15):5747-5758. PubMed ID: 30745359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delineation of molecular determinants for FR900359 inhibition of G
    Boesgaard MW; Harpsøe K; Malmberg M; Underwood CR; Inoue A; Mathiesen JM; König GM; Kostenis E; Gloriam DE; Bräuner-Osborne H
    J Biol Chem; 2020 Oct; 295(40):13850-13861. PubMed ID: 32753482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-affinity and structure-residence time relationships of macrocyclic Gα
    Voss JH; Crüsemann M; Bartling CRO; Kehraus S; Inoue A; König GM; Strømgaard K; Müller CE
    iScience; 2023 Apr; 26(4):106492. PubMed ID: 37091255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-permeable high-affinity tracers for G
    Kuschak M; Namasivayam V; Rafehi M; Voss JH; Garg J; Schlegel JG; Abdelrahman A; Kehraus S; Reher R; Küppers J; Sylvester K; Hinz S; Matthey M; Wenzel D; Fleischmann BK; Pfeifer A; Inoue A; Gütschow M; König GM; Müller CE
    Br J Pharmacol; 2020 Apr; 177(8):1898-1916. PubMed ID: 31881095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An experimental strategy to probe Gq contribution to signal transduction in living cells.
    Patt J; Alenfelder J; Pfeil EM; Voss JH; Merten N; Eryilmaz F; Heycke N; Rick U; Inoue A; Kehraus S; Deupi X; Müller CE; König GM; Crüsemann M; Kostenis E
    J Biol Chem; 2021; 296():100472. PubMed ID: 33639168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-Activity Relationship Studies of the Cyclic Depsipeptide Natural Product YM-254890, Targeting the G
    Zhang H; Xiong XF; Boesgaard MW; Underwood CR; Bräuner-Osborne H; Strømgaard K
    ChemMedChem; 2017 Jun; 12(11):830-834. PubMed ID: 28509439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stabilization of interdomain closure by a G protein inhibitor.
    Todd TD; Vithani N; Singh S; Bowman GR; Blumer KJ; Soranno A
    Proc Natl Acad Sci U S A; 2024 Sep; 121(36):e2311711121. PubMed ID: 39196624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-hypertensive mechanisms of cyclic depsipeptide inhibitor ligands for G
    Meleka MM; Edwards AJ; Xia J; Dahlen SA; Mohanty I; Medcalf M; Aggarwal S; Moeller KD; Mortensen OV; Osei-Owusu P
    Pharmacol Res; 2019 Mar; 141():264-275. PubMed ID: 30634050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering Specificity Determinants for FR900359-Derived G
    Reher R; Kühl T; Annala S; Benkel T; Kaufmann D; Nubbemeyer B; Odhiambo JP; Heimer P; Bäuml CA; Kehraus S; Crüsemann M; Kostenis E; Tietze D; König GM; Imhof D
    ChemMedChem; 2018 Aug; 13(16):1634-1643. PubMed ID: 29873888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationship and conformational studies of the natural product cyclic depsipeptides YM-254890 and FR900359.
    Zhang H; Nielsen AL; Boesgaard MW; Harpsøe K; Daly NL; Xiong XF; Underwood CR; Haugaard-Kedström LM; Bräuner-Osborne H; Gloriam DE; Strømgaard K
    Eur J Med Chem; 2018 Aug; 156():847-860. PubMed ID: 30055466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and Dynamical Basis of G Protein Inhibition by YM-254890 and FR900359: An Inhibitor in Action.
    Tietze D; Kaufmann D; Tietze AA; Voll A; Reher R; König G; Hausch F
    J Chem Inf Model; 2019 Oct; 59(10):4361-4373. PubMed ID: 31539242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted inhibition of G
    Matthey M; Roberts R; Seidinger A; Simon A; Schröder R; Kuschak M; Annala S; König GM; Müller CE; Hall IP; Kostenis E; Fleischmann BK; Wenzel D
    Sci Transl Med; 2017 Sep; 9(407):. PubMed ID: 28904224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total synthesis and structure-activity relationship studies of a series of selective G protein inhibitors.
    Xiong XF; Zhang H; Underwood CR; Harpsøe K; Gardella TJ; Wöldike MF; Mannstadt M; Gloriam DE; Bräuner-Osborne H; Strømgaard K
    Nat Chem; 2016 Nov; 8(11):1035-1041. PubMed ID: 27768111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging of Gα
    Voss JH; Al-Hroub H; Gedschold R; Dietrich JM; Gaffal E; Toma M; Kehraus S; König GM; Brust P; Fleischmann BK; Wenzel D; Deuther-Conrad W; Müller CE
    Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommended Tool Compounds: Application of YM-254890 and FR900359 to Interrogate Gα
    Voss JH
    ACS Pharmacol Transl Sci; 2023 Dec; 6(12):1790-1800. PubMed ID: 38093837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitive LC-MS/MS Method for the Quantification of Macrocyclic Gα
    Kuschak M; Schlegel JG; Schneider M; Kehraus S; Voss JH; Seidinger A; Matthey M; Wenzel D; Fleischmann BK; König GM; Müller CE
    Front Chem; 2020; 8():833. PubMed ID: 33173765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro Module Editing Of NRPS Enables Production Of Highly Potent G
    Hashimoto T; Suenaga H; Amagai K; Hashimoto J; Kozone I; Takahashi S; Shin-Ya K
    Angew Chem Int Ed Engl; 2024 Mar; 63(10):e202317805. PubMed ID: 38238265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting primary and metastatic uveal melanoma with a G protein inhibitor.
    Onken MD; Makepeace CM; Kaltenbronn KM; Choi J; Hernandez-Aya L; Weilbaecher KN; Piggott KD; Rao PK; Yuede CM; Dixon AJ; Osei-Owusu P; Cooper JA; Blumer KJ
    J Biol Chem; 2021; 296():100403. PubMed ID: 33577798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.